Radiology IT firm Sirona Medical raises $42M in Series C financing
Sirona Medical is naming a new CEO after recently raising over $43 million, the San Francisco-based radiology IT firm announced Tuesday.
Dallas venture capital firm Avidity Partners led the Series C financing round with additional contributions from Austin, Texas-based 8VC and GreatPoint Ventures, of San Francisco. Founded in 2018, Sirona Medical offers a cloud-based software that integrates elements of a radiologist’s workflow including task list, viewer, reporter and PACS archive.
The firm launched its product about a year ago and is now naming Hooman Hakami, a former executive at GE HealthCare and Flywheel, as its next CEO. Previous chief, Cameron Andrews, will remain involved with Sirona as president of the board.
"We are entering the next phase in the company's maturity and ability to deliver our next-generation solution to a broader audience while supporting the success of every customer," Andrews said in a Nov. 26 announcement.
Sirona Medical will use the funds to continue improving its platform, including strengthening workflow efficiencies and adding AI-powered report generation. It also plans to bolster customer service and pursue further commercial expansion.
The company’s flagship product is the Sirona Unify, which combines image viewing, reporting and AI on a single platform. It can be deployed as an overlay to existing on-premises picture archiving and communication systems, allowing radiology practices that serve multiple hospitals to combine disparate workflows into one.
Sirona Medical previously closed its $40 million Series B financing round in 2021 and acquired the assets of AI firm Nines in 2022.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.